about
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody produ...
Read More
11.73
0.18
(1.56%)
1.2M
XNAS Volume
XNAS 30 Sep, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Xencor Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..